» Articles » PMID: 12481036

Low Intracellular Zinc Induces Oxidative DNA Damage, Disrupts P53, NFkappa B, and AP1 DNA Binding, and Affects DNA Repair in a Rat Glioma Cell Line

Overview
Specialty Science
Date 2002 Dec 14
PMID 12481036
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 10% of the U.S. population ingests <50% of the current recommended daily allowance for zinc. We investigate the effect of zinc deficiency on DNA damage, expression of DNA-repair enzymes, and downstream signaling events in a cell-culture model. Low zinc inhibited cell growth of rat glioma C6 cells and increased oxidative stress. Low intracellular zinc increased DNA single-strand breaks (comet assay). Zinc-deficient C6 cells also exhibited an increase in the expression of the zinc-containing DNA-repair proteins p53 and apurinic endonuclease (APE). Repletion with zinc restored cell growth and reversed DNA damage. APE is a multifunctional protein that not only repairs DNA but also controls DNA-binding activity of many transcription factors that may be involved in cancer progression. The ability of the transcription factors p53, nuclear factor kappaB, and activator protein 1 (AP1) to bind to consensus DNA sequences was decreased markedly with zinc deficiency, as assayed by electrophoretic mobility-shift assays. Thus, low intracellular zinc status causes oxidative DNA damage and induces DNA-repair protein expression, but binding of p53 and important downstream signals leading to proper DNA repair are lost without zinc.

Citing Articles

Micro- and Macronutrients in Endometrial Cancer-From Metallomic Analysis to Improvements in Treatment Strategies.

Hunek G, Zembala J, Januszewski J, Belzek A, Syty K, Jabiry-Zieniewicz Z Int J Mol Sci. 2024; 25(18).

PMID: 39337406 PMC: 11432114. DOI: 10.3390/ijms25189918.


Association between preoperative serum zinc level and prognosis in patients with advanced esophageal cancer in the neoadjuvant treatment era.

Kubo Y, Igaue S, Utsunomiya D, Kubo K, Kurita D, Ishiyama K Ann Gastroenterol Surg. 2024; 8(4):595-603.

PMID: 38957556 PMC: 11216781. DOI: 10.1002/ags3.12781.


Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers.

Matuszczak M, Kiljanczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P Antioxidants (Basel). 2024; 13(5).

PMID: 38790714 PMC: 11118047. DOI: 10.3390/antiox13050609.


Transient Zn deficiency induces replication stress and compromises daughter cell proliferation.

Holtzen S, Navid E, Kainov J, Palmer A Proc Natl Acad Sci U S A. 2024; 121(19):e2321216121.

PMID: 38687796 PMC: 11087780. DOI: 10.1073/pnas.2321216121.


Oxidative DNA Damage and Zinc Status in Patients With Rheumatoid Arthritis in Duhok, Iraq.

Hassan Sr W Cureus. 2024; 16(1):e52860.

PMID: 38406004 PMC: 10886431. DOI: 10.7759/cureus.52860.


References
1.
Ames B . DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res. 2001; 475(1-2):7-20. DOI: 10.1016/s0027-5107(01)00070-7. View

2.
Lipman T, Diamond A, Mellow M, Patterson K . Esophageal zinc content in human squamous esophageal cancer. J Am Coll Nutr. 1987; 6(1):41-6. DOI: 10.1080/07315724.1987.10720164. View

3.
Shaulian E, Karin M . AP-1 in cell proliferation and survival. Oncogene. 2001; 20(19):2390-400. DOI: 10.1038/sj.onc.1204383. View

4.
Fanzo J, Reaves S, Cui L, Zhu L, Wu J, Wang Y . Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells. Am J Physiol Cell Physiol. 2001; 281(3):C751-7. DOI: 10.1152/ajpcell.2001.281.3.C751. View

5.
Bhatnagar S, Taneja S . Zinc and cognitive development. Br J Nutr. 2001; 85 Suppl 2:S139-45. DOI: 10.1079/bjn2000306. View